Elena V. Bichenkova

Dr. Elena V. Bichenkova

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2004 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
SPSimon J. A. Pope
Simon J. A. Pope
BCBenjamin J. Coe
Benjamin J. Coe
SFStephen Faulkner
Stephen Faulkner
Elena V. BichenkovaElena V. Bichenkova
Elena V. Bichenkova
XYXuan Yu
Xuan Yu
KDKenneth T. Douglas
Kenneth T. Douglas

5 January 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JLJoão Lavrado
João Lavrado
GCGhislain G. Cabal
Ghislain G. Cabal
Miguel PrudêncioMiguel Prudêncio
Miguel Prudêncio
MMMaria M. Mota
Maria M. Mota
JGJiri Gut
Jiri Gut
APAlexandra Paulo
Alexandra Paulo

19 April 2016 in Chemical Communications
Verified
Journal Article
Open access
PDF file
PKPatrick J. S. King
Patrick J. S. King
Alberto SaianiAlberto Saiani
Alberto Saiani
Elena V. BichenkovaElena V. Bichenkova
Elena V. Bichenkova
Aline MillerAline Miller
Aline Miller
The conjugate co-assemblies within the peptide-rich fibres leaving oligonucleotide recognition elements exposed on the external surface of the peptide fibre to ‘ fish out ’ DNA/RNA sequences, leading to a fluorescence response.

1 April 2017 in Biomaterials
Verified
Journal Article
Closed access
OPOlga A. Patutina
Olga A. Patutina
Elena V. BichenkovaElena V. Bichenkova
Elena V. Bichenkova
SMSvetlana Miroshnichenko
Svetlana Miroshnichenko
NMNadezhada L. Mironova
Nadezhada L. Mironova
LTLinda T. Trivoluzzi
Linda T. Trivoluzzi
MZMarina Zenkova
Marina Zenkova

1 May 2010 in Biophysical Journal
Verified
Journal Article
Closed access
FMFelicity L. Mitchell
Felicity L. Mitchell
SMSteven M. Miles
Steven M. Miles
JNJoão Neres
João Neres
Elena V. BichenkovaElena V. Bichenkova
Elena V. Bichenkova
RBRichard A. Bryce
Richard A. Bryce

16 July 2004 in Nucleic Acids Research
Verified
Journal Article
Closed access
NBNatalia G Beloglazova
Natalia G Beloglazova
MFMartin M Fabani
Martin M Fabani
MZMarina Zenkova
Marina Zenkova
Elena V. BichenkovaElena V. Bichenkova
Elena V. Bichenkova
NPNikolai N Polushin
Nikolai N Polushin
VVValentin V Vlassov
Valentin V Vlassov
Antisense oligonucleotide conjugates, bearing constructs with two imidazole residues, were synthesized using a precursor-based technique employing post-synthetic histamine functionalization of oligonucleotides bearing methoxyoxalamido precursors at the 5'-termini. The conjugates were assessed in terms of their cleavage activities using both biochemical assays and conformational analysis by molecular modelling. The oligonucleotide part of the conjugates was complementary to the T-arm of yeast tRNA(Phe) (44-60 nt) and was expected to deliver imidazole groups near the fragile sequence C61-ACA-G65 of the tRNA. The conjugates showed ribonuclease activity at neutral pH and physiological temperature resulting in complete cleavage of the target RNA, mainly at the C63-A64 phosphodiester bond. For some constructs, cleavage was completed within 1-2 h under optimal conditions. Molecular modelling was used to determine the preferred orientation(s) of the cleaving group(s) in the complexes of the conjugates with RNA target. Cleaving constructs bearing two imidazole residues were found to be conformationally highly flexible, adopting no preferred specific conformation. No interactions other than complementary base pairing between the conjugates and the target were found to be the factors stabilizing the 'active' cleaving conformation(s).